Macrophages associated with tumors as potential targets and therapeutic intermediates

Serguei Vinogradov1, Galya Warren, Xin Wei

  • 1Department of Pharmaceutical Sciences, College of Pharmacy, University of Nebraska Medical Center, Omaha, NE 68198-6025, USA.

Insights

Tumor-associated macrophages (TAMs) are key drivers of tumor growth. Targeting TAMs with nanomedicine offers a promising strategy for enhancing cancer therapy and inhibiting tumor progression.

Area of Science:

  • Immunology
  • Oncology
  • Nanomedicine

Background:

  • Tumor-associated macrophages (TAMs) constitute a significant portion of the tumor mass, actively promoting tumor progression by suppressing immune responses, promoting angiogenesis, and supporting cancer stem cells.
  • The inherent mobility of TAMs within tumors presents a potential avenue for improving the distribution of nanocarriers and achieving effective tumor growth inhibition.

Purpose of the Study:

  • To compare the characteristics of macrophages and TAMs relevant for TAM-directed cancer therapies.
  • To highlight the advantages of nanomedicine in drug delivery, particularly the preferential uptake of nanocarriers by macrophages.
  • To review current strategies for reprogramming or inhibiting the tumor-promoting functions of TAMs and explore combination therapies with nanodrugs.

Main Methods:

  • Comparative analysis of macrophage and TAM features.
  • Review of nanomedicine applications in drug delivery and cancer therapy.
  • Discussion of recent research on TAM reprogramming and inhibition strategies.

Main Results:

  • TAMs play a critical role in tumor growth and progression.
  • Nanomedicine offers advantages for targeted drug delivery to TAMs.
  • Strategies exist to modulate TAM functions and enhance chemotherapy efficacy.

Conclusions:

  • Targeting TAMs is a crucial strategy in novel cancer therapeutics.
  • Nanomedicine-based approaches show significant potential for TAM-directed therapies.
  • Combining nanodrug delivery with conventional chemotherapy could improve treatment outcomes.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.3K
The Tumor Microenvironment02:17

The Tumor Microenvironment

2.7K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.0K